NASDAQ · APEN
Apollo Endosurgery, Inc.
$10.00$0.00 (0.0%)
Apollo Endosurgery, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.91% below the high.
Loading market information…
NASDAQ · SHCR · USD
Stock price, earnings
Quote as of Oct 21, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Sharecare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Sharecare, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Sharecare, Inc. functions as a provider of digital healthcare platforms. Its central platform acts as a nexus, uniting a diverse ecosystem of individuals, patients, healthcare providers, employers, health insurance companies, government agencies, and local communities, all with the goal of fostering improved health outcomes for both individuals and the wider population. The company delivers enterprise-grade solutions via a Software-as-a-Service (SaaS) framework, empowering corporate clients to effectively communicate with, inspire, and oversee the well-being of their constituents, while also monitoring their collective advancement. Additionally, Sharecare offers a comprehensive array of data-centric and informational tools, alongside specialized life sciences offerings. These provide users with customized information, structured programs, and essential resources tailored to boost their overall health and vitality. A key offering is RealAge, its proprietary health assessment platform. This tool evaluates users' lifestyles and pre-existing medical conditions, subsequently yielding a quantifiable measure of their physical health. Furthermore, the company supplies medical institutions with secure, automated information release, auditing, and strategic business consulting services, all designed to optimize and simplify the management of medical records. Sharecare's services are distributed through a dual approach: a dedicated direct sales force complemented by strategic partnerships. Established in 2009, Sharecare's corporate headquarters are situated in Atlanta, Georgia.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2023 | May 10, 2023 | -$0.03-66.67% vs estimate | $116.30M+4.86% vs estimate |
|---|
| Q4 2022 | Mar 29, 2023 | -$0.07-40.0% vs estimate | $123.26M+2.51% vs estimate |
|---|
THE ANALYST VIEW
4 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.00$0.00 (0.0%)
Apollo Endosurgery, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.91% below the high.
$7.02$0.00 (0.0%)
Accolade, Inc.’s quoted price sits in the upper half of its reported 52-week range, 27.4% below the high.
$8.68$0.00 (0.0%)
Sage Therapeutics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 7.26% below the high.
$18.99$0.00 (0.0%)
ZimVie Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.11% below the high.
$23.73-$0.27 (-1.13%)
Claritev Corporation’s quoted price sits in the lower half of its reported 52-week range, 67.79% below the high.
$2.10-$0.10 (-4.55%)
SomaLogic, Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.59% below the high.
$23.15-$0.36 (-1.53%)
MultiPlan Corporation’s quoted price sits in the upper half of its reported 52-week range, 39.85% below the high.
$10.50+$0.09 (+0.86%)
Tabula Rasa HealthCare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
